Propanc Biopharma, Inc Common Stock
Yahoo Finance • 28 days ago
Propanc Biopharma Signs MOU With Avance To Advance Phase 1b, FIH Of PRP In Solid Tumours; Stock Down
(RTTNews) - Propanc Biopharma, Inc. (PPCB) announced that it has signed a Memorandum of Understanding (MOU) with Avance Clinical Pty Ltd, an Australia-based full-service Contract Research Organization, with the intention to collaborate for... Full story
Yahoo Finance • 2 months ago
Propanc Biopharma’s CEO Tours European CDMO & Plans for GMP Production of PRP for Phase 1b, FIH Study
MELBOURNE, Australia, June 16, 2026 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company focused on developing novel treatments for chronic diseases, including recurrent and... Full story
Yahoo Finance • 2 months ago
Pre-Market Movers: BYAH, LXEO, ELTX Swing Big
(RTTNews) - Biotech companies are seeing significant pre-market activity this Monday. Price swings ahead of the opening bell are being driven by clinical trial and regulatory updates, as well as trial endpoint misses. In the Green - Prem... Full story
Yahoo Finance • 2 months ago
ShareStructure.io Announces Investor Education Platform on Public Company Financing Activity.
Boca Raton, United States, June 11, 2026 (GLOBE NEWSWIRE) -- ShareStructure.io is proud to announce the launch of its free financial education and research platform focused on helping investors better understand public company capital s... Full story
Yahoo Finance • 2 months ago
Propanc Biopharma’s CEO Attends Keynote Address, “Rejuvenation and Health: Science for an Ageing Society,” at the University of Granada, Spain
MELBOURNE, Australia, June 02, 2026 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company focused on developing novel treatments for chronic diseases, including recurrent and... Full story
Yahoo Finance • 3 months ago
Propanc Biopharma Implements Reverse Stock Split to Support Continued Nasdaq Listing and Growth Plans
MELBOURNE, Australia , May 13, 2026 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company focused on developing novel treatments for chronic diseases, including recurrent and... Full story
Yahoo Finance • 5 months ago
Propanc Biopharma Executes Service Agreement with FyoniBio to Establish & Validate Pharmacokinetics Assay for Phase 1b First-In-Human Study
MELBOURNE, Australia, March 10, 2026 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company focused on developing novel treatments for chronic diseases, including recurrent an... Full story